Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
McKinsey
US Department of Justice
Baxter
Deloitte
Fish and Richardson
Farmers Insurance
Medtronic
Argus Health

Generated: May 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,241,907

« Back to Dashboard

Which drugs does patent 7,241,907 protect, and when does it expire?

Patent 7,241,907 protects JEVTANA KIT and is included in one NDA.

Protection for JEVTANA KIT has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has forty patent family members in thirty-five countries.
Summary for Patent: 7,241,907
Title:Acetone solvate of dimethoxy docetaxel and its process of preparation
Abstract:This invention discloses and claims an acetone solvate of dimethoxydocetaxel or 4-acetoxy-2.alpha.-benzoyloxy-5.beta.,20-epoxy-1-hydroxy-7.beta.,10.beta.- -dimethoxy-9-oxotax-11-en-13.alpha.-yl (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate and its preparation by crystallization from an aqueous/acetone solution.
Inventor(s): Didier; Eric (Paris, FR), Perrin; Marc-Antoine (Jouy en Josas, FR)
Assignee: Aventis Pharma S.A. (Antony, FR)
Application Number:10/944,254
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,241,907
Patent Claim Types:
see list of patent claims
Compound; Use; Process;

Drugs Protected by US Patent 7,241,907

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Sanofi Aventis Us JEVTANA KIT cabazitaxel SOLUTION;IV (INFUSION) 201023-001 Jun 17, 2010 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,241,907

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France03 11016Sep 19, 2003

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Deloitte
Covington
Federal Trade Commission
Farmers Insurance
Daiichi Sankyo
US Army
US Department of Justice
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.